Anixa Biosciences, Inc. (ANIX)
2.65
-0.12
(-4.33%)
USD |
NASDAQ |
Mar 20, 16:00
2.93
+0.28
(+10.57%)
After-Hours: 20:00
Anixa Biosciences Total Assets (Quarterly) : 15.23M for Jan. 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.564B |
| Agenus, Inc. | 226.80M |
| Alnylam Pharmaceuticals, Inc. | 5.026B |
| Savara, Inc. | 253.44M |
| Arrowhead Pharmaceuticals, Inc. | 1.604B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.387M |
| Shareholders Equity (Quarterly) | 15.08M |
| Debt to Equity Ratio | 0.0128 |
| Current Ratio | 12.18 |
| Net Debt Paydown Yield | 0.01% |